Clinical Trial Update: Intravenous Versus Oral Administration of Prednisolone in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing intravenous and oral prednisolone for COPD exacerbations has completed, assessing whether the route of administration affects outcomes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: Isala | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED